SlideShare a Scribd company logo
IMPLANT DRUG DELIVERY
SYSTEM
Presented by
Dasara Thanmayi
ABSTRACT
Implantable drug delivery systems are being
developed to release drugs to the blood stream
continuously as well as free patients from being
hospitalized to receive intravenous infusions or
frequent injections. One technique is implantation of
a pellet in the subcutaneous tissue so the pellet may
be released by erosion. Drugs are also diffused
through silicone rubber capsules but only poly
acrylamide is able to release large molecules .
Contraceptive rings containing progesterone and
placed in the uterus or vagina and implanted silicone
rubber capsules use these principles.
INTRODUCTION
 Implants are intended for implantation in the
body(usually subcutaneously) for the purpose of providing
continuous release of the drug over long period of time.
 Implants are administered by means of a suitable special
injection or surgical incision.
 These are developed with a view to transmit drugs and
fluids into the blood stream with out the repeated insertion
of needles.
 These systems are particularly suited to the drug delivery
requirements of insulin, steroids, chemotherapeutics,
antibiotics, analgesics, trial parenteral nutrition and heparin.
IDEAL PROPERTIES OF IMPLANTS:
 Bio-stable
 Bio-compatible
 Easily removable
 Non toxic and non-carcinogenic
 Minimum surface area and smooth texture
 Rate controlled release of the drug
 Non-irritant
 Non-antigenic
 Non-thrombogenic
 Should be long reservoir
 Better life
 Easy programmable
ENVIRONMENTALLY STABLE :
Should not breakdown under the influence of heat, light, air
and moisture.
BIO-STABLE :
Should not undergo physicochemical degradation when in
contact with bio-fluids.
BIO-COMPATIBLE :
Should neither stimulate immune responses (otherwise the
implant will be rejected) nor thrombosis and fibrosis
formation.
NON-TOXIC AND NON-CARCINOGENIC :
It’s degradation products or leached additives must be
completely safe.
ADVANTAGES
 Unattended continuous delivery within the
therapeutic window.
 Avoids the highly variable peak and trough
concentrations.
 Enhanced drug efficacy.
 Minimized side effects.
 Termination of therapy as and when required.
 Patient compliance is also a benefit of continuous
dosing with these implants as they operate for a long
period of time once implanted.
DISADVANTAGES
 Mini surgery is needed (painful).
 Uneasy to simple discontinue the therapy.
 Local reactions.
 Inadequate release.
 The reaction between host and implant.
 Implantation procedure is difficult in the case of larger
implants
 Requires small surgery for large implantation and painful.
APPLICATIONS:
 CANCER TREATMENT:
 GLIADEL WAFER: Delivers carmustine for the
treatment of brain tumors directly at the site of tumor to
prevent re-occurence of tumors.
 DEPOCYTE: Cytarabine releasing implantable drug
delivery system used to treat acute leukemia.
 DUROS OSMOTIC PUMP: Non bio degardable drug
delivery system used to (treat acute)deliver leoprolide
acetate in the treatment of prostate cancer.
 OSTEOPOROSIS:
 MICROCHIPS: This device made by ELI Lilly co
workers used to deliver for drug used to increase
bone density in patients suffering from severe
osteoporosis.
 OCULAR DISEASE:
 LACRIMEDICS: These are collagen implants used
to treat eye syndrome by partially blocking tear
removing canals and they dissolve within 7-10 days.
LIMITATIONS OF IMPLANTS
 Possible toxicity.
 Need for microsurgery to implant the system.
 Possible pain.
 Difficulty in shutting off release if necessary.
CLASSIFICATION
I. IN-SITU DEPOT FORMING SYSTEM
a) In-situ precipitating implant.
b) In-situ microparticulate implant.
c) In-situ gels.
d) In-situ cross linked gels.
I. SOLID IMPLANTS
II. INFUSION IMPLANTS
IN-SITU DEPOT FORMING SYSTEM
 In-situ depot forming system transform into semi-
solids upon injection and provide sustained release
of pharmacological agents.
 Including small molecule drugs, peptides.
EXAMPLE :ATRIGEL(PLGA + water)
SABER(sucrose acetate isobutyrate
ALZAMER(PLGA + solvent)
IN-SITU PRECIPITATING IMPLANT
 PREPARATION:
Polymeric solutions of 20%,30% and 40% dissolved in
PLGA,DMSO by shaking in an environment shaker at a
room temperature for up to 72hrs.
A clear polymeric solution was obtained and 300 mg of
MK was added to a calibrated amber glass vial and 3 ml
polymeric solution measured by 3ml syringe and added to
vial.
drug is completely dissolved in polymeric solution
volume was adjusted to 3ml calibration mark and mix well
after 24hrs.
 ADVANTAGES :
 Reduces the side effects.
 Improved patient compliance.
 DISADVANTAGES:
 Need for reconstitution before injection.
 Inability to remove the dose once injected.
 Relatively complicated manufacturing procedures to
produce a sterile,stable.
IN-SITU MICROPARTICULATE
IMPLANT
 A polymeric solution of 30% PLGA in NMP
was prepared this polymeric phase was emulsified
into an external peanut oil phase at three different
polymer to oil phase ratios of 1:1,1:2 and 1:4.
 The emulsification process was achieved by probe
sonication using branson sonifier 250 at output of
250w
 Frequency of 20KHZ for 30s under ice cooling
 Pluronic F6s based on the amount of the total
formulation was dissolved in the polymer phase and
aluminum monosterate in the oil phase to increase
the stability of the emulsion.
 DISADVANTAGES
 High injection force.
 Local irritation at the injection site.
IN-SITU GELS
 A proprietary parenteral in-situ gel delivery system
is ATRIGEL system.
 Used for both parenteral and site specific drug
delivery.
 Liquid formulations generating a semisolid depot
after adminstration into the body are attractive
delivery system.
 When the liquid polymer system is placed in the
body using standard needles and syringes.
 In-situ gels are drugs delivery systems that are in
solution form before administration in the body but
once administered undergo gelation in situ to form a
gel.
 In-situ routes for in situ gels :
oral, ocular, rectal, vaginal, injectable and intra-
peritoneal routes.
IN-SITU CROSS LINKED GELS
 Gel site polymer is a natural acidic polysaccharide.
 Extracted and purified from the aloe plant.
 The polymer in an aqueous solution forms a gel in
the presence of calcium.
 When injected subcutaneously or intramuscularly
thus entrapping a water soluble drug in the solution
and providing sustained release.
SOLID IMPLANTS
 Implants are cylindrical , monolithic devices of mm
or cm dimensions .
 Implanted by a minor surgical incision or injected
through a large bone needle into the subcutaneously.
 Subcutaneous tissue is an ideal location because of
its poor perfusion.
 Slow drug absorption.
 The drug in implants may be dissolved or dispersed
in a matrix of polymer or waxes that control release
by dissolution, bioerosin or biodegradation.
 Polymers used are silicone elastomers ,
polymethacrylates, polycaprolactone.
 While waxes include glycerol monostearate.
INFUSION DEVICES
These are implantable devices but are
versatile in the sense that they are intrinsically
powered to release the medicament at a zero order
rate and the drug reservoir can be replenished from
time to time . Depending upon the mechanism by
which these implantable pumps are powered to
release the contents,they are classified into
following types:
I. OSMOTIC PRESSURE ACTIVATED DRUG
DELIVERY SYSTEM.
II. VAPOUR PRESSURE ACTIVATED DRUG
DELIVERY SYSTEM.
III. BATTERY POWERED DRUG DELIVERY
SYSTEM.
 OSMOTIC PRESSURE POWERED SYSTEM
a) ALZET osmotic pump.
b) DUROS infusion pump.
ALZET OSMOTIC PUMP
 It is a miniaturized system that provides zero order
delivery of biologically active molecules and has
been extensively used in animal studies by
researchers throughout the world.
 The ALZET pumps are capsular in shape and made
in a variety of sizes. the pump is made of three
concentric layers.
1. The innermost drug reservoir contained in a
collapsible impermeable polyester bag(which is
open to the exterior via a single portal).
2. An intermediate sleeve of dry osmotic energy
source(sodium chloride).
3. The outer most rigid , rate controlling semi
permeable membrane fabricated from substituted
cellulosic polymers.
EXAMPLE : Ionized drugs , macromolecules ,
steroids and peptides.
 A rigid polymeric plug is used to form a leak proof
seal between the drug reservoir and the semi
permeable housing.
 An additional component , the flow modulator
,comprising of a cap and a tube made of stainless
steel is inserted into the body of osmotic pump after
filling.
 After implantation water from the surrounding tissue
fluids is imbibed through the semi permeable
membrane at a controlled rate that dissolves the
osmogent creating an osmotic pressure differential
across the membrane.
 The osmotic sleeve thus expands and since the outer
wall is rigid it squeezes the inner flexible drug
reservoir and the drug solution is expelled in a
constant volume per unit time.
DUROS INFUSION IMPLANT
 The duros osmotic implant is a non-biodegradable ,
miniature titanium cylinder intended to enable
systemic or tissue specific therapy for small
molecule drugs , peptides, proteins, DNA and other
bioactive molecules.
 The implant which is inserted subcutaneously and
retrieved at the end of the treatment duration is
designed to precisely and the continuously deliver
drugs for periods ranging from one month to more
than a year.
EXAMPLE :Leuprolide acetate implant.
 In a DUROS system , a protein or peptide is
formulated into a stable solution or suspension
which is protected by the water resistant , non
erodible , ,sterilized drug reservoir .
 The outer titanium alloy cylinder is capped by a
semi-permeable membrane at one end and by an exit
port at the other end.
 Within the DUROS system is implanted in the
human body , water from surrounding tissue enters
one end of the cylinder through the semi permeable
membrane causing the osmotic engine to swell.
 This osmotic engine displaces a piston which in turn
causes the drug formulation to be released from a
port at the other end of the system.
VAPOUR PRESSURE POWRERED
PUMP
 This device is based on the principle that at a given
temperature a liquid in equilibrium with its vapour
phase exerts a constant pressure that is independent
of enclosing pump.
 The disc shaped devices consists of two chambers.
 An infusate chamber containing the drug solution
which is separated by a freely movable flexible
bellow from the vapor chamber containing
inexhaustible vaporizable fluid such as flurocarbons.
 After implantation the volatile liquid vaporizes at
the body temperature and creates a vapor pressure
that compresses the bellows and expels the infusate
through a series of flow regulators at a constant rate.
EXAMPLE: Insulin for diabetics
Morphine.
BATTERY POWERED PUMPS
 Two types of battery powered implantable
programmable pumps used to deliver insulin are
PERISTALTIC PUMP AND SOLENOID DRIVEN
RECIPROCATING PUMP.
 Both with electronic controls.
 The systems can be programmed to deliver the drug
at desired rates.
 Their design is such that the drug moves towards the
exit and there is no backflow of infusate.
REFERENCES
 WWW.SYSREVPHARM .ORG
 NOVEL DRUG DELIVERY EDITED BY
W.CHEIN.

More Related Content

What's hot

Approaches to Targeted Delivery of Drugs
Approaches to Targeted Delivery of DrugsApproaches to Targeted Delivery of Drugs
Approaches to Targeted Delivery of Drugs
wonderingsoul114
 
gastro retentive drug delivery system advantages and approaches
gastro retentive drug delivery system advantages and approachesgastro retentive drug delivery system advantages and approaches
gastro retentive drug delivery system advantages and approaches
mangasrinivas37
 
Intrauterine drug delivery system
Intrauterine drug delivery systemIntrauterine drug delivery system
Intrauterine drug delivery system
Aloysiatreslyn
 
buccal drug delivery system
buccal drug delivery systembuccal drug delivery system
buccal drug delivery system
rasikawalunj
 
Gastro Retentive Drug Delivery System
Gastro Retentive Drug Delivery SystemGastro Retentive Drug Delivery System
Gastro Retentive Drug Delivery System
Dr Gajanan Sanap
 
1 gastroretentive drug delivery systems
1 gastroretentive drug delivery systems1 gastroretentive drug delivery systems
1 gastroretentive drug delivery systemsAkash Aher
 
Gastro retentive drug delivery system (GRDDS)
Gastro retentive drug delivery system (GRDDS)Gastro retentive drug delivery system (GRDDS)
Gastro retentive drug delivery system (GRDDS)
Shweta Nehate
 
Approaches for the design of transdermal drug delivery
Approaches for the design of transdermal drug deliveryApproaches for the design of transdermal drug delivery
Approaches for the design of transdermal drug delivery
kvineetha8
 
formulation of Buccal Drug Delivery System.pptx
formulation of Buccal Drug Delivery System.pptxformulation of Buccal Drug Delivery System.pptx
formulation of Buccal Drug Delivery System.pptx
PawanDhamala1
 
Factors affecting TRANSDERMAL DRUG DELIVERY SYSTEM
Factors affecting TRANSDERMAL DRUG DELIVERY SYSTEMFactors affecting TRANSDERMAL DRUG DELIVERY SYSTEM
Factors affecting TRANSDERMAL DRUG DELIVERY SYSTEM
Siddu K M
 
Controlled Release Drug Delivery Systems - Types, Methods and Applications
Controlled Release Drug Delivery Systems - Types, Methods and ApplicationsControlled Release Drug Delivery Systems - Types, Methods and Applications
Controlled Release Drug Delivery Systems - Types, Methods and Applications
Suraj Choudhary
 
Mucoadhesive drug delivery system
Mucoadhesive drug delivery systemMucoadhesive drug delivery system
Mucoadhesive drug delivery system
Jamia Hamdard
 
Transdermal Drug Delivery System (TDDS)
Transdermal Drug Delivery System (TDDS)Transdermal Drug Delivery System (TDDS)
Transdermal Drug Delivery System (TDDS)
PRABU12345678
 
Alzet osmotic pumps
Alzet osmotic pumpsAlzet osmotic pumps
Alzet osmotic pumps
Arul Packiadhas
 
Controlled release drug delivery system2
Controlled release drug delivery system2Controlled release drug delivery system2
Controlled release drug delivery system2
Bansari Patel
 
Factors affecting design of Controlled Release Drug Delivery Systems (write-up)
Factors affecting design of Controlled Release Drug Delivery Systems (write-up)Factors affecting design of Controlled Release Drug Delivery Systems (write-up)
Factors affecting design of Controlled Release Drug Delivery Systems (write-up)
Suraj Choudhary
 
Bioadhesive drug delivery system
Bioadhesive drug delivery systemBioadhesive drug delivery system
Bioadhesive drug delivery systemDr. Shreeraj Shah
 
Targeted Drug Delivery Systems
Targeted Drug Delivery SystemsTargeted Drug Delivery Systems
Targeted Drug Delivery Systems
SURYAKANTVERMA2
 
Mucosal Drug Delivery System
Mucosal Drug Delivery SystemMucosal Drug Delivery System
Mucosal Drug Delivery System
SwatiSen3
 

What's hot (20)

Approaches to Targeted Delivery of Drugs
Approaches to Targeted Delivery of DrugsApproaches to Targeted Delivery of Drugs
Approaches to Targeted Delivery of Drugs
 
gastro retentive drug delivery system advantages and approaches
gastro retentive drug delivery system advantages and approachesgastro retentive drug delivery system advantages and approaches
gastro retentive drug delivery system advantages and approaches
 
Intrauterine drug delivery system
Intrauterine drug delivery systemIntrauterine drug delivery system
Intrauterine drug delivery system
 
buccal drug delivery system
buccal drug delivery systembuccal drug delivery system
buccal drug delivery system
 
Gastro Retentive Drug Delivery System
Gastro Retentive Drug Delivery SystemGastro Retentive Drug Delivery System
Gastro Retentive Drug Delivery System
 
1 gastroretentive drug delivery systems
1 gastroretentive drug delivery systems1 gastroretentive drug delivery systems
1 gastroretentive drug delivery systems
 
Gastro retentive drug delivery system (GRDDS)
Gastro retentive drug delivery system (GRDDS)Gastro retentive drug delivery system (GRDDS)
Gastro retentive drug delivery system (GRDDS)
 
Approaches for the design of transdermal drug delivery
Approaches for the design of transdermal drug deliveryApproaches for the design of transdermal drug delivery
Approaches for the design of transdermal drug delivery
 
formulation of Buccal Drug Delivery System.pptx
formulation of Buccal Drug Delivery System.pptxformulation of Buccal Drug Delivery System.pptx
formulation of Buccal Drug Delivery System.pptx
 
Factors affecting TRANSDERMAL DRUG DELIVERY SYSTEM
Factors affecting TRANSDERMAL DRUG DELIVERY SYSTEMFactors affecting TRANSDERMAL DRUG DELIVERY SYSTEM
Factors affecting TRANSDERMAL DRUG DELIVERY SYSTEM
 
Gastroretentive Drug Delivery System
Gastroretentive Drug Delivery SystemGastroretentive Drug Delivery System
Gastroretentive Drug Delivery System
 
Controlled Release Drug Delivery Systems - Types, Methods and Applications
Controlled Release Drug Delivery Systems - Types, Methods and ApplicationsControlled Release Drug Delivery Systems - Types, Methods and Applications
Controlled Release Drug Delivery Systems - Types, Methods and Applications
 
Mucoadhesive drug delivery system
Mucoadhesive drug delivery systemMucoadhesive drug delivery system
Mucoadhesive drug delivery system
 
Transdermal Drug Delivery System (TDDS)
Transdermal Drug Delivery System (TDDS)Transdermal Drug Delivery System (TDDS)
Transdermal Drug Delivery System (TDDS)
 
Alzet osmotic pumps
Alzet osmotic pumpsAlzet osmotic pumps
Alzet osmotic pumps
 
Controlled release drug delivery system2
Controlled release drug delivery system2Controlled release drug delivery system2
Controlled release drug delivery system2
 
Factors affecting design of Controlled Release Drug Delivery Systems (write-up)
Factors affecting design of Controlled Release Drug Delivery Systems (write-up)Factors affecting design of Controlled Release Drug Delivery Systems (write-up)
Factors affecting design of Controlled Release Drug Delivery Systems (write-up)
 
Bioadhesive drug delivery system
Bioadhesive drug delivery systemBioadhesive drug delivery system
Bioadhesive drug delivery system
 
Targeted Drug Delivery Systems
Targeted Drug Delivery SystemsTargeted Drug Delivery Systems
Targeted Drug Delivery Systems
 
Mucosal Drug Delivery System
Mucosal Drug Delivery SystemMucosal Drug Delivery System
Mucosal Drug Delivery System
 

Similar to Implant drug delivery system

Implant : Challenging Drug Delivery System
Implant : Challenging Drug Delivery SystemImplant : Challenging Drug Delivery System
Implant : Challenging Drug Delivery System
biniyapatel
 
Ndds 6 Implantable Drug Delivery System
Ndds 6 Implantable Drug Delivery SystemNdds 6 Implantable Drug Delivery System
Ndds 6 Implantable Drug Delivery System
shashankc10
 
Implants
ImplantsImplants
Implants
TridevSastri1
 
Implants
ImplantsImplants
Implants
ImplantsImplants
Implants
mostafaokda255
 
Implantable drug delivery system
Implantable drug delivery systemImplantable drug delivery system
Implantable drug delivery system
PAWAN TIKTE
 
Implants
ImplantsImplants
Implants
ImplantsImplants
Implants
sushmita rana
 
Presentation on implants
Presentation  on implantsPresentation  on implants
Presentation on implants
suchitrauppicherla
 
Implant infusion pump & ophthalmic inserts.
Implant infusion pump & ophthalmic inserts.Implant infusion pump & ophthalmic inserts.
Implant infusion pump & ophthalmic inserts.
Abhishek Dhoot
 
Novel approaches to parenteral drug delivery system
Novel approaches to parenteral drug delivery systemNovel approaches to parenteral drug delivery system
Novel approaches to parenteral drug delivery system
Karrolla Shiny
 
Parental Implants
Parental ImplantsParental Implants
Parental Implants
MdAwaisIqbal
 
IMPLANTABLE DRUG DELIVERY SYSTEMS and it's application
IMPLANTABLE DRUG DELIVERY SYSTEMS and it's applicationIMPLANTABLE DRUG DELIVERY SYSTEMS and it's application
IMPLANTABLE DRUG DELIVERY SYSTEMS and it's application
AshwiniRaikar1
 
Types of parenteral formulations
Types of parenteral formulationsTypes of parenteral formulations
Types of parenteral formulations
University Institute of Pharmaceutical Sciences
 
Implantable drug delivery systems
Implantable drug delivery systemsImplantable drug delivery systems
Implantable drug delivery systems
AkankshaPatel55
 
Implantable dds ppt mali vv
Implantable dds ppt mali vvImplantable dds ppt mali vv
Implantable dds ppt mali vv
VidhyaMali1
 
Microparticulate injectable implants insitue depot
Microparticulate injectable implants insitue depotMicroparticulate injectable implants insitue depot
Microparticulate injectable implants insitue depot
dinesh sancheti
 
Implants- B.Pharm SEM 7- Novel Drug Delivery System
Implants- B.Pharm SEM 7- Novel Drug Delivery SystemImplants- B.Pharm SEM 7- Novel Drug Delivery System
Implants- B.Pharm SEM 7- Novel Drug Delivery System
vedanshu malviya
 
Parenteral Products
Parenteral ProductsParenteral Products
Parenteral Products
Komal Sathe
 

Similar to Implant drug delivery system (20)

Implant : Challenging Drug Delivery System
Implant : Challenging Drug Delivery SystemImplant : Challenging Drug Delivery System
Implant : Challenging Drug Delivery System
 
Ndds 6 Implantable Drug Delivery System
Ndds 6 Implantable Drug Delivery SystemNdds 6 Implantable Drug Delivery System
Ndds 6 Implantable Drug Delivery System
 
Implants
ImplantsImplants
Implants
 
Implants
ImplantsImplants
Implants
 
Implants
ImplantsImplants
Implants
 
Implantable drug delivery system
Implantable drug delivery systemImplantable drug delivery system
Implantable drug delivery system
 
Implants
ImplantsImplants
Implants
 
Implants
ImplantsImplants
Implants
 
Presentation on implants
Presentation  on implantsPresentation  on implants
Presentation on implants
 
Implant infusion pump & ophthalmic inserts.
Implant infusion pump & ophthalmic inserts.Implant infusion pump & ophthalmic inserts.
Implant infusion pump & ophthalmic inserts.
 
Novel approaches to parenteral drug delivery system
Novel approaches to parenteral drug delivery systemNovel approaches to parenteral drug delivery system
Novel approaches to parenteral drug delivery system
 
Parental Implants
Parental ImplantsParental Implants
Parental Implants
 
IMPLANTABLE DRUG DELIVERY SYSTEMS and it's application
IMPLANTABLE DRUG DELIVERY SYSTEMS and it's applicationIMPLANTABLE DRUG DELIVERY SYSTEMS and it's application
IMPLANTABLE DRUG DELIVERY SYSTEMS and it's application
 
Types of parenteral formulations
Types of parenteral formulationsTypes of parenteral formulations
Types of parenteral formulations
 
Implantable drug delivery systems
Implantable drug delivery systemsImplantable drug delivery systems
Implantable drug delivery systems
 
Implantable dds ppt mali vv
Implantable dds ppt mali vvImplantable dds ppt mali vv
Implantable dds ppt mali vv
 
Microparticulate injectable implants insitue depot
Microparticulate injectable implants insitue depotMicroparticulate injectable implants insitue depot
Microparticulate injectable implants insitue depot
 
Implants- B.Pharm SEM 7- Novel Drug Delivery System
Implants- B.Pharm SEM 7- Novel Drug Delivery SystemImplants- B.Pharm SEM 7- Novel Drug Delivery System
Implants- B.Pharm SEM 7- Novel Drug Delivery System
 
Parenteral Products
Parenteral ProductsParenteral Products
Parenteral Products
 
Depot preparations
Depot preparationsDepot preparations
Depot preparations
 

Recently uploaded

263778731218 Abortion Clinic /Pills In Harare ,
263778731218 Abortion Clinic /Pills In Harare ,263778731218 Abortion Clinic /Pills In Harare ,
263778731218 Abortion Clinic /Pills In Harare ,
sisternakatoto
 
Superficial & Deep Fascia of the NECK.pptx
Superficial & Deep Fascia of the NECK.pptxSuperficial & Deep Fascia of the NECK.pptx
Superficial & Deep Fascia of the NECK.pptx
Dr. Rabia Inam Gandapore
 
BENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdf
BENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdfBENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdf
BENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdf
DR SETH JOTHAM
 
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
Oleg Kshivets
 
micro teaching on communication m.sc nursing.pdf
micro teaching on communication m.sc nursing.pdfmicro teaching on communication m.sc nursing.pdf
micro teaching on communication m.sc nursing.pdf
Anurag Sharma
 
heat stroke and heat exhaustion in children
heat stroke and heat exhaustion in childrenheat stroke and heat exhaustion in children
heat stroke and heat exhaustion in children
SumeraAhmad5
 
Ocular injury ppt Upendra pal optometrist upums saifai etawah
Ocular injury  ppt  Upendra pal  optometrist upums saifai etawahOcular injury  ppt  Upendra pal  optometrist upums saifai etawah
Ocular injury ppt Upendra pal optometrist upums saifai etawah
pal078100
 
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTSARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
Dr. Vinay Pareek
 
Physiology of Chemical Sensation of smell.pdf
Physiology of Chemical Sensation of smell.pdfPhysiology of Chemical Sensation of smell.pdf
Physiology of Chemical Sensation of smell.pdf
MedicoseAcademics
 
Pharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptx
Pharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptxPharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptx
Pharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptx
Dr. Rabia Inam Gandapore
 
Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx
Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptxMaxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx
Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx
Dr. Rabia Inam Gandapore
 
For Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #Girls
For Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #GirlsFor Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #Girls
For Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #Girls
Savita Shen $i11
 
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdf
ARTIFICIAL INTELLIGENCE IN  HEALTHCARE.pdfARTIFICIAL INTELLIGENCE IN  HEALTHCARE.pdf
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdf
Anujkumaranit
 
Novas diretrizes da OMS para os cuidados perinatais de mais qualidade
Novas diretrizes da OMS para os cuidados perinatais de mais qualidadeNovas diretrizes da OMS para os cuidados perinatais de mais qualidade
Novas diretrizes da OMS para os cuidados perinatais de mais qualidade
Prof. Marcus Renato de Carvalho
 
BRACHYTHERAPY OVERVIEW AND APPLICATORS
BRACHYTHERAPY OVERVIEW  AND  APPLICATORSBRACHYTHERAPY OVERVIEW  AND  APPLICATORS
BRACHYTHERAPY OVERVIEW AND APPLICATORS
Krishan Murari
 
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdfAlcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
Dr Jeenal Mistry
 
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists  Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Saeid Safari
 
Ophthalmology Clinical Tests for OSCE exam
Ophthalmology Clinical Tests for OSCE examOphthalmology Clinical Tests for OSCE exam
Ophthalmology Clinical Tests for OSCE exam
KafrELShiekh University
 
Knee anatomy and clinical tests 2024.pdf
Knee anatomy and clinical tests 2024.pdfKnee anatomy and clinical tests 2024.pdf
Knee anatomy and clinical tests 2024.pdf
vimalpl1234
 
KDIGO 2024 guidelines for diabetologists
KDIGO 2024 guidelines for diabetologistsKDIGO 2024 guidelines for diabetologists
KDIGO 2024 guidelines for diabetologists
د.محمود نجيب
 

Recently uploaded (20)

263778731218 Abortion Clinic /Pills In Harare ,
263778731218 Abortion Clinic /Pills In Harare ,263778731218 Abortion Clinic /Pills In Harare ,
263778731218 Abortion Clinic /Pills In Harare ,
 
Superficial & Deep Fascia of the NECK.pptx
Superficial & Deep Fascia of the NECK.pptxSuperficial & Deep Fascia of the NECK.pptx
Superficial & Deep Fascia of the NECK.pptx
 
BENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdf
BENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdfBENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdf
BENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdf
 
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
 
micro teaching on communication m.sc nursing.pdf
micro teaching on communication m.sc nursing.pdfmicro teaching on communication m.sc nursing.pdf
micro teaching on communication m.sc nursing.pdf
 
heat stroke and heat exhaustion in children
heat stroke and heat exhaustion in childrenheat stroke and heat exhaustion in children
heat stroke and heat exhaustion in children
 
Ocular injury ppt Upendra pal optometrist upums saifai etawah
Ocular injury  ppt  Upendra pal  optometrist upums saifai etawahOcular injury  ppt  Upendra pal  optometrist upums saifai etawah
Ocular injury ppt Upendra pal optometrist upums saifai etawah
 
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTSARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
 
Physiology of Chemical Sensation of smell.pdf
Physiology of Chemical Sensation of smell.pdfPhysiology of Chemical Sensation of smell.pdf
Physiology of Chemical Sensation of smell.pdf
 
Pharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptx
Pharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptxPharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptx
Pharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptx
 
Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx
Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptxMaxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx
Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx
 
For Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #Girls
For Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #GirlsFor Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #Girls
For Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #Girls
 
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdf
ARTIFICIAL INTELLIGENCE IN  HEALTHCARE.pdfARTIFICIAL INTELLIGENCE IN  HEALTHCARE.pdf
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdf
 
Novas diretrizes da OMS para os cuidados perinatais de mais qualidade
Novas diretrizes da OMS para os cuidados perinatais de mais qualidadeNovas diretrizes da OMS para os cuidados perinatais de mais qualidade
Novas diretrizes da OMS para os cuidados perinatais de mais qualidade
 
BRACHYTHERAPY OVERVIEW AND APPLICATORS
BRACHYTHERAPY OVERVIEW  AND  APPLICATORSBRACHYTHERAPY OVERVIEW  AND  APPLICATORS
BRACHYTHERAPY OVERVIEW AND APPLICATORS
 
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdfAlcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
 
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists  Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
 
Ophthalmology Clinical Tests for OSCE exam
Ophthalmology Clinical Tests for OSCE examOphthalmology Clinical Tests for OSCE exam
Ophthalmology Clinical Tests for OSCE exam
 
Knee anatomy and clinical tests 2024.pdf
Knee anatomy and clinical tests 2024.pdfKnee anatomy and clinical tests 2024.pdf
Knee anatomy and clinical tests 2024.pdf
 
KDIGO 2024 guidelines for diabetologists
KDIGO 2024 guidelines for diabetologistsKDIGO 2024 guidelines for diabetologists
KDIGO 2024 guidelines for diabetologists
 

Implant drug delivery system

  • 2. ABSTRACT Implantable drug delivery systems are being developed to release drugs to the blood stream continuously as well as free patients from being hospitalized to receive intravenous infusions or frequent injections. One technique is implantation of a pellet in the subcutaneous tissue so the pellet may be released by erosion. Drugs are also diffused through silicone rubber capsules but only poly acrylamide is able to release large molecules . Contraceptive rings containing progesterone and placed in the uterus or vagina and implanted silicone rubber capsules use these principles.
  • 3. INTRODUCTION  Implants are intended for implantation in the body(usually subcutaneously) for the purpose of providing continuous release of the drug over long period of time.  Implants are administered by means of a suitable special injection or surgical incision.  These are developed with a view to transmit drugs and fluids into the blood stream with out the repeated insertion of needles.  These systems are particularly suited to the drug delivery requirements of insulin, steroids, chemotherapeutics, antibiotics, analgesics, trial parenteral nutrition and heparin.
  • 4. IDEAL PROPERTIES OF IMPLANTS:  Bio-stable  Bio-compatible  Easily removable  Non toxic and non-carcinogenic  Minimum surface area and smooth texture  Rate controlled release of the drug  Non-irritant  Non-antigenic  Non-thrombogenic  Should be long reservoir  Better life  Easy programmable
  • 5. ENVIRONMENTALLY STABLE : Should not breakdown under the influence of heat, light, air and moisture. BIO-STABLE : Should not undergo physicochemical degradation when in contact with bio-fluids. BIO-COMPATIBLE : Should neither stimulate immune responses (otherwise the implant will be rejected) nor thrombosis and fibrosis formation. NON-TOXIC AND NON-CARCINOGENIC : It’s degradation products or leached additives must be completely safe.
  • 6. ADVANTAGES  Unattended continuous delivery within the therapeutic window.  Avoids the highly variable peak and trough concentrations.  Enhanced drug efficacy.  Minimized side effects.  Termination of therapy as and when required.  Patient compliance is also a benefit of continuous dosing with these implants as they operate for a long period of time once implanted.
  • 7. DISADVANTAGES  Mini surgery is needed (painful).  Uneasy to simple discontinue the therapy.  Local reactions.  Inadequate release.  The reaction between host and implant.  Implantation procedure is difficult in the case of larger implants  Requires small surgery for large implantation and painful.
  • 8. APPLICATIONS:  CANCER TREATMENT:  GLIADEL WAFER: Delivers carmustine for the treatment of brain tumors directly at the site of tumor to prevent re-occurence of tumors.  DEPOCYTE: Cytarabine releasing implantable drug delivery system used to treat acute leukemia.  DUROS OSMOTIC PUMP: Non bio degardable drug delivery system used to (treat acute)deliver leoprolide acetate in the treatment of prostate cancer.
  • 9.  OSTEOPOROSIS:  MICROCHIPS: This device made by ELI Lilly co workers used to deliver for drug used to increase bone density in patients suffering from severe osteoporosis.  OCULAR DISEASE:  LACRIMEDICS: These are collagen implants used to treat eye syndrome by partially blocking tear removing canals and they dissolve within 7-10 days.
  • 10. LIMITATIONS OF IMPLANTS  Possible toxicity.  Need for microsurgery to implant the system.  Possible pain.  Difficulty in shutting off release if necessary.
  • 11. CLASSIFICATION I. IN-SITU DEPOT FORMING SYSTEM a) In-situ precipitating implant. b) In-situ microparticulate implant. c) In-situ gels. d) In-situ cross linked gels. I. SOLID IMPLANTS II. INFUSION IMPLANTS
  • 12. IN-SITU DEPOT FORMING SYSTEM  In-situ depot forming system transform into semi- solids upon injection and provide sustained release of pharmacological agents.  Including small molecule drugs, peptides. EXAMPLE :ATRIGEL(PLGA + water) SABER(sucrose acetate isobutyrate ALZAMER(PLGA + solvent)
  • 13. IN-SITU PRECIPITATING IMPLANT  PREPARATION: Polymeric solutions of 20%,30% and 40% dissolved in PLGA,DMSO by shaking in an environment shaker at a room temperature for up to 72hrs. A clear polymeric solution was obtained and 300 mg of MK was added to a calibrated amber glass vial and 3 ml polymeric solution measured by 3ml syringe and added to vial. drug is completely dissolved in polymeric solution volume was adjusted to 3ml calibration mark and mix well after 24hrs.
  • 14.  ADVANTAGES :  Reduces the side effects.  Improved patient compliance.  DISADVANTAGES:  Need for reconstitution before injection.  Inability to remove the dose once injected.  Relatively complicated manufacturing procedures to produce a sterile,stable.
  • 15. IN-SITU MICROPARTICULATE IMPLANT  A polymeric solution of 30% PLGA in NMP was prepared this polymeric phase was emulsified into an external peanut oil phase at three different polymer to oil phase ratios of 1:1,1:2 and 1:4.  The emulsification process was achieved by probe sonication using branson sonifier 250 at output of 250w
  • 16.  Frequency of 20KHZ for 30s under ice cooling  Pluronic F6s based on the amount of the total formulation was dissolved in the polymer phase and aluminum monosterate in the oil phase to increase the stability of the emulsion.  DISADVANTAGES  High injection force.  Local irritation at the injection site.
  • 17. IN-SITU GELS  A proprietary parenteral in-situ gel delivery system is ATRIGEL system.  Used for both parenteral and site specific drug delivery.  Liquid formulations generating a semisolid depot after adminstration into the body are attractive delivery system.  When the liquid polymer system is placed in the body using standard needles and syringes.
  • 18.  In-situ gels are drugs delivery systems that are in solution form before administration in the body but once administered undergo gelation in situ to form a gel.  In-situ routes for in situ gels : oral, ocular, rectal, vaginal, injectable and intra- peritoneal routes.
  • 19. IN-SITU CROSS LINKED GELS  Gel site polymer is a natural acidic polysaccharide.  Extracted and purified from the aloe plant.  The polymer in an aqueous solution forms a gel in the presence of calcium.  When injected subcutaneously or intramuscularly thus entrapping a water soluble drug in the solution and providing sustained release.
  • 20. SOLID IMPLANTS  Implants are cylindrical , monolithic devices of mm or cm dimensions .  Implanted by a minor surgical incision or injected through a large bone needle into the subcutaneously.  Subcutaneous tissue is an ideal location because of its poor perfusion.  Slow drug absorption.
  • 21.  The drug in implants may be dissolved or dispersed in a matrix of polymer or waxes that control release by dissolution, bioerosin or biodegradation.  Polymers used are silicone elastomers , polymethacrylates, polycaprolactone.  While waxes include glycerol monostearate.
  • 22. INFUSION DEVICES These are implantable devices but are versatile in the sense that they are intrinsically powered to release the medicament at a zero order rate and the drug reservoir can be replenished from time to time . Depending upon the mechanism by which these implantable pumps are powered to release the contents,they are classified into following types:
  • 23. I. OSMOTIC PRESSURE ACTIVATED DRUG DELIVERY SYSTEM. II. VAPOUR PRESSURE ACTIVATED DRUG DELIVERY SYSTEM. III. BATTERY POWERED DRUG DELIVERY SYSTEM.  OSMOTIC PRESSURE POWERED SYSTEM a) ALZET osmotic pump. b) DUROS infusion pump.
  • 24. ALZET OSMOTIC PUMP  It is a miniaturized system that provides zero order delivery of biologically active molecules and has been extensively used in animal studies by researchers throughout the world.
  • 25.  The ALZET pumps are capsular in shape and made in a variety of sizes. the pump is made of three concentric layers. 1. The innermost drug reservoir contained in a collapsible impermeable polyester bag(which is open to the exterior via a single portal). 2. An intermediate sleeve of dry osmotic energy source(sodium chloride). 3. The outer most rigid , rate controlling semi permeable membrane fabricated from substituted cellulosic polymers. EXAMPLE : Ionized drugs , macromolecules , steroids and peptides.
  • 26.  A rigid polymeric plug is used to form a leak proof seal between the drug reservoir and the semi permeable housing.  An additional component , the flow modulator ,comprising of a cap and a tube made of stainless steel is inserted into the body of osmotic pump after filling.  After implantation water from the surrounding tissue fluids is imbibed through the semi permeable membrane at a controlled rate that dissolves the osmogent creating an osmotic pressure differential across the membrane.  The osmotic sleeve thus expands and since the outer wall is rigid it squeezes the inner flexible drug reservoir and the drug solution is expelled in a constant volume per unit time.
  • 27. DUROS INFUSION IMPLANT  The duros osmotic implant is a non-biodegradable , miniature titanium cylinder intended to enable systemic or tissue specific therapy for small molecule drugs , peptides, proteins, DNA and other bioactive molecules.  The implant which is inserted subcutaneously and retrieved at the end of the treatment duration is designed to precisely and the continuously deliver drugs for periods ranging from one month to more than a year. EXAMPLE :Leuprolide acetate implant.
  • 28.  In a DUROS system , a protein or peptide is formulated into a stable solution or suspension which is protected by the water resistant , non erodible , ,sterilized drug reservoir .
  • 29.  The outer titanium alloy cylinder is capped by a semi-permeable membrane at one end and by an exit port at the other end.  Within the DUROS system is implanted in the human body , water from surrounding tissue enters one end of the cylinder through the semi permeable membrane causing the osmotic engine to swell.  This osmotic engine displaces a piston which in turn causes the drug formulation to be released from a port at the other end of the system.
  • 30. VAPOUR PRESSURE POWRERED PUMP  This device is based on the principle that at a given temperature a liquid in equilibrium with its vapour phase exerts a constant pressure that is independent of enclosing pump.
  • 31.  The disc shaped devices consists of two chambers.  An infusate chamber containing the drug solution which is separated by a freely movable flexible bellow from the vapor chamber containing inexhaustible vaporizable fluid such as flurocarbons.  After implantation the volatile liquid vaporizes at the body temperature and creates a vapor pressure that compresses the bellows and expels the infusate through a series of flow regulators at a constant rate. EXAMPLE: Insulin for diabetics Morphine.
  • 32. BATTERY POWERED PUMPS  Two types of battery powered implantable programmable pumps used to deliver insulin are PERISTALTIC PUMP AND SOLENOID DRIVEN RECIPROCATING PUMP.  Both with electronic controls.  The systems can be programmed to deliver the drug at desired rates.  Their design is such that the drug moves towards the exit and there is no backflow of infusate.
  • 33. REFERENCES  WWW.SYSREVPHARM .ORG  NOVEL DRUG DELIVERY EDITED BY W.CHEIN.